Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention
The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal.
These Stocks Are Moving the Most Today: Nvidia, Tesla, Boeing, Autodesk, Gilead, Signet, Williams-Sonoma, and More
Nvidia stock rises after the chip maker makes a number of product announcements at its annual AI GTC conference, Tesla trades ...
Us Weekly2h
‘Handmaid’s Tale’ Season 6 Trailer Shows Return to Gilead Amid Rebellion, Teases Potential Spinoff
The official trailer for The Handmaid's Tale's final season shows June (Elisabeth Moss) returning to Gilead amid a revolution ...
Gilead Stock Falls on Report U.S. Could Slash HIV-Prevention Budget
The Health and Human Services Department is weighing plans to drastically cut funding for domestic HIV prevention, The Wall Street Journal reported. + The cuts could af ...
Gilead Stock (NYSE:GILD) Slumps on HIV Funding Cuts Report
Gilead Sciences (GILD) stock fell after The Wall Street Journal reported that the Health and Human Services Department is looking at ...
HIV Drug Makers Get Spooked by Possible Trump Cut, but Impact Looks Manageable
Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is largely due to excitement over its [long-acting HIV prevention drug]( ...
Schaeffer's Investment Research5h
Gilead Sciences Stock Slips on Possible HIV Funding Cut
Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is ...
Wall Street weighs in on Gilead as shares fall on possible U.S. HIV cuts
Investing.com -- Gilead Sciences shares dropped more than 3% Wednesday following a Wall Street Journal report that the Health ...
Gilead drops 3% to $107 after WSJ report of HIV funding cuts
EDT Gilead (GILD) drops 3% to $107 after WSJ report of HIV funding cutsLight Up your Portfolio with Spark:Easily identify stocks' risks ...
Gilead: Growth Constraints Lead To Rating Downgrade Following 50% Rally
So, assuming 2% growth, Gilead is slightly undervalued. In fact, Gilead appears valued for 0% growth. Actually, this may be a ...
Watch The Handmaid’s Tale final season trailer: "This is the beginning of the end"
The series also marks the departure of showrunner Bruce Miller, who has moved on to developing The Handmaid's Tale sequel ...